Associate Professor Billingsley Kaambwa

Head of Health Economics

College of Medicine and Public Health

place Health Sciences
GPO Box 2100, ADELAIDE, SA, 5001

Billingsley Kaambwa is an Associate Professor of Health Economics and the Head of Health Economics in the College of Medicine and Public Health. He currently serves on the Evaluation Sub-Committee of the Australian Medical Services Advisory Committee (MSAC), which advises the Commonwealth Department of Health on the public funding of novel medical services. Previously, Billingsley has advised the Economics Sub Committee (ESC) of the Pharmaceutical Benefits Advisory Committee (PBAC) and was a member of an MSAC panel for Health Technology Assessment (HTA) services. Additionally, he is a member of the New Health Technology and Clinical Practice Innovation Committee (NHTCPIC) for the Southern Adelaide Local Health Network (SALHN). The NHTCPIC provides governance, policy advice, and independent evidence reviews regarding the safe, clinical-, and cost-effective introduction of new, emerging, and existing health technologies in SALHN. Billingsley's extensive research and teaching experience focus on applying econometric and statistical techniques to choice modelling, decision-analytic modelling, and economic evaluations of healthcare technologies. In recognition of his sustained research contributions, he was ranked among the World’s Top 2% of Researchers in 2024 by the Stanford University Global Rankings.

He has been a co-applicant on successful grant applications that total more than $40 million. This includes 24 Category 1 grants (MRFF, NHMRC, and NIHR-funded projects), including 7 MRFF grants, 3 NHMRC Ideas Grants, 1 NHMRC Project Grant and 1 NHMRC CRE. He has also secured 8 Category 2 grants (including from RACGP and the Commonwealth Departments of Health and Veterans’ Affairs) and 14 Category 3 grants (including from Flinders Foundation, Breakthrough Mental Health Research Foundation, and the Emergency Medicine Foundation).

He sits on the editorial boards of 'PLoS One' and 'PharmacoEconomics Open'. He has published in leading international peer-reviewed journals for both methodological (e.g. Value in Health, BMC series) and applied (e.g. The Lancet, JAMA, European Journal of Health Economics, PharmacoEconomics, PLoS One) work.

An almost up-to-date list of publications is available on GOOGLE SCHOLAR.

Qualifications
  • PhD in Health Economics
  • DIP in Applied Statistics
  • MA in Health Economics
  • BA in Economics and Statistical Mathematics
Honours, awards and grants
  • A randomised controlled trial of multi-night screening and diagnosis of obstructive sleep apnoea to improve diagnostic test accessibility, accuracy and reduce costs (MRFF). Funder: NHMRC; Timescale: 5 years; Start date: 07/2024; Value: $1,995,310.
  • Novel home monitoring and integrated support program of obstructive sleep apnea management (MRFF).. Funder: NHMRC; Timescale: 4 years; Start date: 07/2024; Value: $1,496,448.
  • SIMPLIFI-OSA - A Study to Investigate the Management of Patients using LImited channel testing versus Full polysomnography for Identification of Obstructive Sleep Apnea (MRFF). Funder: NHMRC; Timescale: 4 years; Start date: 07/2024; Value: $1,995,310.
  • Chronic insomnia: comparing the effectiveness of interventions utilising digital health in priority population (MRFF). Funder: NHMRC; Timescale: 3 years; Start date: 03/2024; Value: $1,319,463.
  • Supporting self-management of lymphoedema after breast cancer. Co-design and implementation of a Lymphoedema Navigation Online (LeaN On) Program (MRFF). Funder: NHMRC; Timescale: 3 years; Start date: 03/2024; Value: $598,546
  • Electronic Patient REPorted Outcome MeAsures for REmote Symptom Monitoring (The PREPARES Implementation study) (MRFF). Funder: NHMRC; Timescale: 4 years; Start date: 05/2023; Value: $744,287
  • safe@home: effectiveness and cost effectiveness of telemonitoring and virtual care supported by primary care for people living with chronic disease in low socioeconomic neighbourhoods for reducing ambulance ramping, readmission and GP clinic block (Partnership Projects). Funder: NHMRC; Timescale: 4 years; Start date: 05/2023; Value: $1,125,678
  • A novel targeted approach to deliver treatable trait-based precision medicine for obstructive sleep apnoea” (2021 MRFF Chronic Respiratory Conditions). Funder: NHMRC; Timescale: 5 years; Start date: 03/2023; Value: $1,999,634
  • Bacteriophages: a new paradigm in caring for infected wounds. (Ideas Grants). Funder: NHMRC; Timescale: 2 years; Start date: 01/2023; Value: $759,818
  • Development and Evaluation of Lived Experience Peer Support Intervention for Mental Health Service Users in Primary Care. (2021 MRFF Consumer-Led Research). Funder: NHMRC; Timescale: 3 years; Start date: 01/2023; Value: $599,664
  • Knowledge interface co-design of a diabetes and metabolic syndrome intervention with and for Aboriginal and Torres Strait Islander peoples living on Ngarrindjeri country. (2021 MRFF Indigenous Health Research). Funder: NHMRC; Timescale: 3 years; Start date: 06/2022; Value: $756,623
  • Improving the management of Obstructive Sleep Apnea and Insomnia in General Practice. (Partnership projects). Funder: NHMRC; Timescale: 4 years; Start date: 04/2021; Value: $ 1,471,965
Key responsibilities
  • Health Economics research on a number of NHMRC, MRFF and ARC projects
  • Consultancy
  • Health Economics teaching on postgraduate programmes at Flinders and Adelaide Universities
  • Health Economics teaching on undergraduate programmes at Flinders University
  • Postgraduate research student supervision (PhD, MSc and Honours students)
Teaching interests
  • Health Economics
  • Economic Evaluation
  • Econometrics
  • Introduction to Health Economics
  • Public Health
  • Health Equity
  • Environmental Economics
Topic coordinator
PHCA2513 Health Equity
PHCA1507 Introduction to Public Health
Topic lecturer
PHCA2513 Health Equity
PHCA1507 Introduction to Public Health